Mercaptopurine
Nucleoside Metabolic Inhibitor
NADAC/unit
$1.0410
No Shortage
Tier 1: 39.8%
PA Req: 20.7%
3 Manufacturers
4 ANDAs
Mercaptopurine interferes with DNA synthesis to slow cancer cell or viral replication.
Generic Manufacturers
DR REDDYS LABORATORIES SAHIKMA PHARMACEUTICALS USA INCMYLAN PHARMACEUTICALS INCNOVA LABORATORIES LTDSTASON PHARMACEUTICALS INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
